Program Overview

Intercalated Pharmacology and Innovative Therapeutics

Overview

The Intercalated Pharmacology and Innovative Therapeutics BSc is a one-year program designed for students already taking a medical or dental degree. This program provides an appreciation of the scientific foundations of clinical medicine and the study of the scientific basis of pharmacology and the clinical trials industry.

Key Information

• Degree: BSc (Intercal)
• Duration: 1 year
• Start: September 2026
• UCAS code: B212
• Institution code: Q50
• Entry Requirements: Full entry requirements, including contextual admissions
• Home fees: £9,535
• Overseas fees: £32,950

Program Structure

The program can be started after the second, third, or fourth years of an MBBS, BDS, or BVetMed. The structure includes:

• Compulsory Modules:
  • Intercalated Research Project
  • Classic Papers and Current Topics in Pharmacology
  • Clinical Trials and Regulatory Affairs
  • Drug Design for Pharmacologists
  • Translational Pharmacology and Innovative Therapeutics
• Optional Modules (Choose one):
  • Biomarkers in Neuroscience
  • Cancer Biology
  • Molecular Basis of Personalised Medicine
  • Stem Cells and Regenerative Medicine

Teaching and Learning

Students receive approximately three hours of weekly contact time per taught module, including formal lectures from NHS colleagues and specialists from abroad. For every hour spent in class, students complete a further six hours of independent study.

Assessment

Assessment typically includes a combination of written exams, coursework essays, journal clubs, and oral presentations, and project write-up.

Resources and Facilities

The School offers excellent on-campus resources, including iLab research facilities, imaging facilities, and the Genome Centre.

Entry Requirements

The program considers every application on its individual merits, taking into account individual educational experiences and context. Non-UK students are welcome to apply, and English language requirements must be met.

Funding

UK students are eligible to apply for loans and grants from Student Finance England or other government bodies. Medical and dental students from Barts and The London may be considered for various bursaries based on research interests, financial need, or academic merit.

Careers

The program forms a strong basis for careers in academic medicine, with a focus on pharmacological research. It also provides an advantage in clinical work or within the pharmaceutical and clinical trials industry.

About the School

The William Harvey Research Institute, part of the Faculty of Medicine and Dentistry at Queen Mary University of London, is one of the largest pharmacological research institutes in the UK university sector. The Institute offers education programs at undergraduate, postgraduate, and research levels, taught by world-leading experts in cardiovascular, endocrine, and inflammation research.